Alibaba Health Information Technology (HKG:0241) recorded a 65% rise in attributable profit for the six months ended Sept. 30 to 1.27 billion yuan from 769 million yuan in the year-ago period, a Wednesday Hong Kong bourse filing said.
The internet service provider for the medical and pharmaceutical sector saw earnings per share of 0.0782 yuan, up from 0.0478 yuan in the corresponding period of the last year.
Revenue in the six months increased 17% to 16.7 billion yuan from 14.3 billion yuan a year prior.
The higher profit was mainly due to growth in the pharmaceutical direct sales, as well as the healthcare and pharmaceutical e-commerce platform business wings.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.